Silencing ATAD2 inhibited ESCC cell growth and lung metastasis in vivo, and the knockdown of ATAD2 inhibited ESCC migration and invasion in vitro41. This evidence concerns the gene ATAD2 and esophageal squamous cell carcinoma.